By making pharmacogenomic information prompt, accessible, and understandable for physicians, The Center for Personalized Therapeutics leads the way in translating genomic discovery to improved care for patients.

Each Person is Genetically Unique

Announcements

The Twelve Hundred Patients Project, headed by Dr. Peter O'Donnell, was featured in Crain's Chicago Business's article "What's cooking in Illinois research labs?". One of first five projects funded by University of Illinois' venture fund.

Dr. Peter O'Donnell and the 1200 Patients Project featured on PGRN website for July 2014

Dr. Peter O'Donnell is a featured investigator and the 1200 Patients Project is a featured research project for the month of July on the Pharmacogenomics Research Network (PGRN) website. View the PGRN website feature here

Dr. Michael Maitland wins prestigious award

Michael Maitland, M.D., Ph.D. has been selected as the 2012 ASCPT Leon I Goldberg Young Investigator Award by the members of the ASCPT Scientific Awards Selection Task Force. Dr. Maitland will be honored at the upcoming ASCPT Annual Meeting in March.

Nancy Cox, Ph.D Appointed to AAAS Biological Sciences Section

Mark Ratain, MD Named as Honorary Fellow by the American College of Clinical Pharmacology

Mark Ratain, MD, the Leon O. Jacobson Professor of Medicine, Chairman, Committee on Clinical Pharmacology and Pharmacogenomics and Director of the Center for Personalized Therapeutics is the 2011 recipient of the American College of Clinical Pharmacology’s (ACCP) Honorary Fellow Award. This award recognizes Dr. Ratain’s expertise in the use of investigational agents for the treatment of advanced solid tumors. Dr.

Mark Ratain, MD, the Leon O. Jacobson Professor of Medicine at the University of Chicago, has been awarded the Translational Research Professorship for 2011 by the American Society for Clinical Oncology's Conquer Cancer Foundation.

The award, according to the foundation, provides "flexible funding to outstanding translational researchers who have made, and are continuing to make, significant contributions that have changed the direction of cancer research and who provide mentorship to future translational researchers."

The 1200 Patients Project

Physicians and patients have become increasingly aware that people often react or respond to medications very differently, even when a medication is being used to treat the same condition.

Recent research shows that our individual genetic makeup often explains why we tolerate or respond to a given drug. This knowledge has led to the identification of genetic factors governing response and toxicity for hundreds of drugs. Such knowledge continues to increase all the time. Read More...